<DOC>
	<DOCNO>NCT01934816</DOCNO>
	<brief_summary>This study aim examine involvement KATP channel microvascular action incretin GLP-1 analogue healthy individual determine whether acute oral administration different KATP channel blocker oral medication Type 2 diabetes Glibenclamide Glimepiride differentially modulate microvascular response individual .</brief_summary>
	<brief_title>Incretin KATP Channels</brief_title>
	<detailed_description>In addition glucose lower effect , incretin base therapy also effect vascular system . Previous animal work initial human study suggest incretins may cardioprotective act vasodilator open KATP channel . Initial evidence suggest beneficial vascular effect incretin modify agent may nullify co-current treatment sulfonylurea ( SU ) drug glibenclamide . The investigator hypothesis GLP-1 SUs may conflict effect KATP channel thus vascular function . Interestingly vascular action GLP-1 modify different treatment SUs call glimepiride , thereby raise possibility SUs differentially modulate vascular action GLP-1 though remain controversial .</detailed_description>
	<mesh_term>Incretins</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>BMI ≤ 25 kg/m2 current past history diabetes ( HbA1C equal 45mmol/mol ) history postprandial hypoglycaemia dump syndrome establish cardiovascular disease establish cerebrovascular disease blood pressure ≥ 140/85 mmHg Raynaud 's disease severe impairment renalhepatic , thyroid adrenocortical function current treatment antihypertensive treatment lipid lower therapy systemic steroid lactation , pregnancy establish vascular disease bariatric surgery significant weight change within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Incretins , KATP channel , intradermal injection</keyword>
</DOC>